Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison

Sutton, Andrew J.; Edmunds, W. John; Gill, O. Noel
January 2006
BMC Public Health;2006, Vol. 6, p170
Academic Journal
Background: In England and Wales where less than 1% of the population are Injecting drug users (IDUs), 97% of HCV reports are attributed to injecting drug use. As over 60% of the IDU population will have been imprisoned by the age of 30 years, prison may provide a good location in which to offer HCV screening and treatment. The aim of this work is to examine the cost effectiveness of a number of alternative HCV case-finding strategies on prison reception Methods: A decision analysis model embedded in a model of the flow of IDUs through prison was used to estimate the cost effectiveness of a number of alternative case-finding strategies. The model estimates the average cost of identifying a new case of HCV from the perspective of the health care provider and how these estimates may evolve over time. Results: The results suggest that administering verbal screening for a past positive HCV test and for ever having engaged in illicit drug use prior to the administering of ELISA and PCR tests can have a significant impact on the cost effectiveness of HCV case-finding strategies on prison reception; the discounted cost in 2017 being £2,102 per new HCV case detected compared to £3,107 when no verbal screening is employed. Conclusion: The work here demonstrates the importance of targeting those individuals that have ever engaged in illicit drug use for HCV testing in prisons, these individuals can then be targeted for future intervention measures such as treatment or monitored to prevent future transmission.


Related Articles

  • Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6. Kobayashi, Mariko; Chayama, Kazuaki; Arase, Yasuji; Tsubota, Akihito; Saitoh, Satoshi; Suzuki, Yoshiyuki; Kobayashi, Masahiro; Ikeda, Kenji; Matsuda, Marie; Koike, Hiromi; Hashimoto, Michie; Kumada, Hiromitsu // Journal of Gastroenterology;1999, Vol. 34 Issue 4, p505 

    Abstract: By conventional serological grouping methods, it is possible to determine hepatitis C virus (HCV) serological groups for genotypes la, and lb, and genotypes 2a, and 2b, but not for other genotypes, i.e., 3a, 3b, 4a, 5a, and 6a. In this study, we attempted to serologically group HCV...

  • The Current Seroprevalence of Hepatitis C Virus in a Tertiary Care Centre in Vellore, Tamil Nadu. Gowri, V.; Chandraleka, C.; Vanaja, R. // Indian Journal of Community Medicine;Apr-Jun2012, Vol. 37 Issue 2, p137 

    A letter to the editor is presented about the status of hepatitis C virus infection in Vellore, Tamil Nadu, India.

  • Chronic Hepatitis C Virus Infection. Flamm, Steven L. // JAMA: Journal of the American Medical Association;5/14/2003, Vol. 289 Issue 18, p2413 

    Focuses on Chronic Hepatitis C Virus (HCV) a disease which effects people worldwide. How HCV is an RNA virus; Epidemiology; How percutaneous exposure is the most common mode of transmission; Tests run to detect the presence of HCV including the enzyme immunoassay test; Treatments for the disease.

  • Age-wise seroprevalence of hepatitis C virus infection in clinically suspected infectious hepatitis patients attending a tertiary care hospital in Delhi. Rajani, Monika; Jais, Manoj // International Journal of Medicine & Public Health;Jan-Mar2014, Vol. 4 Issue 1, p78 

    Introduction: Hepatitis C is a major public health problem globally. There are limited studies on age and sex related prevalence of hepatitis C virus (HCV). As hepatitis C is a preventable disease, the burden of the disease could be reduced to a signifi cant extent if its seroprevalence is...

  • A Study of the Interaction between Hepatitis C Virus Infection and Pulmonary Disorders: Assessment of Interferon Gamma and Alpha-1-Antitrypsin. Ezzeldin, Nada; Saad-Hussein, Amal; Radwan, Mohamed; El-Lebedy, Dalia; Kafoury, Mona; Fraouk, Hebatallah; Kandil, Dina // Macedonian Journal of Medical Sciences;Mar2014, Vol. 7 Issue 1, p40 

    Objectives: To study lung diseases in chronic HCV infection and vice versa and to find immunological and/or hereditary interrelating factors. Material and Methods: Study included 134 individuals, all were subjected to screening for anti- HCV antibodies by ELISA, HCV-RNA by real time PCR,...

  • Anti-Hepatitis C Antibodies in Patients with Chronic Non-A, Non-B Hepatitis: Relation to Disease Progression and Effect of Interferon α. Yoshioka, Kentaro; Kakumu, Shinichi; Hayashi, Hisao; Shinagawa, Tadashi; Wakita, Takaji; Ishikawa, Tetsuya; Itoh, Yuji; Takayanagi, Masahiro // American Journal of Gastroenterology;Oct1991, Vol. 86 Issue 10, p1495 

    The activity of antibodies to hepatitis C virus (anti-HCV) was investigated in 80 patients with chronic non-A, non-B liver diseases. Serum anti-HCV titer was determined by the "Ortho-HCV" enzyme-linked immunosorbent assay with some modifications to quantify the activity. Anti-HCV was positive in...

  • Expression of immunoreactive forms of the hepatitis C NS5A protein in E. coli and their use for diagnostic assays. Kalamvoki, M.; Miriagou, V.; Hadziyannis, A.; Georgopoulou, U.; Varaklioti, A.; Hadziyannis, S.; Mavromara, P. // Archives of Virology;Sep2002, Vol. 147 Issue 9, p1733 

    Summary. In this study different forms of the hepatitis C virus (HCV) NS5A protein, including a nearly full-length, an amino-terminal and a carboxy-terminal truncated form were produced in E. coli as fusion proteins with the MBP or the GST protein. The chimeric proteins were tested for their...

  • Comparison of third generation ELISA and conventional nested RT-PCR for detection of HCV among hemodialysis patients. Prakash, Shantanu; Sankhwar, S. N.; Jain, Amita; Usman, Kausar; Prasad, Narayan; Saha, D.; Singh, K. P.; Jain, Parul; Singh, Desh Deepak // Journal of Applied Pharmaceutical Science;Aug2014, Vol. 4 Issue 8, p018 

    Hepatitis C virus is one of the main cause of chronic hepatitis in developing countries. The current study was done to evaluate the efficacy of the third generation ELISA compared to nested RT- PCR for establishing the diagnosis of hepatitis C virus (HCV) in patients on hemodialysis. This...

  • Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Knudsen, Freddy; Wantzin, Per; Rasmussen, Knud; Ladefoged, Søren D.; Løkkegaard, Niels; Rasmussen, Lars S.; Lassen, Anders; Krogsgaard, Kim // Kidney International;Jun1993, Vol. 43 Issue 6, p1353 

    Antibodies to hepatitis C virus (anti-HCV) were determined in an unselected group of 340 patients with chronic renal failure treated with maintenance dialysis. A second generation hepatitis C virus (HCV) enzyme-linked immunosorbent assay (ELISA) was used and confirmation made by a second...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics